Author:
Shukla Divya,Nandave Mukesh,Kumar Anoop,Siwan Deepali
Publisher
Springer Nature Singapore
Reference55 articles.
1. [CIOMS] C for IO of MS (2005) Current Challenges in pharmacovigilance: pragmatic approaches. Report CIOMS Work Gr V, Geneva CI- OMS. (4):345. http://www.sciencedirect.com/science/article/B6VC6-45F5X02-. Accessed 12 Sept 2023
2. Abiri OT, Johnson WCN (2019) Pharmacovigilance systems in resource-limited settings: an evaluative case study of Sierra Leone. J Pharm Policy Pract 12:13
3. Adenuga BA, Kibuule D, Bamitale KDS, Rennie TW (2020) Effective integration of pharmacovigilance systems at public health facilities in resource-limited settings: a qualitative study. Res Social Adm Pharm 16(8):1111–1116
4. Almenoff J, Tonning JM, Gould AL, Szarfman A, Hauben M, Ouellet-Hellstrom R et al (2005) Perspectives on the use of data mining in pharmacovigilance. Drug Saf 28(11):981–1007
5. Al-Zubiedi SA, Younus M, Al-Khalidi S, Ekilo M, Alshammari TM (2023) Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic. Expert Opin Drug Saf 22(2):165–174